New insights into viral structure and virus-cell interactions through proteomics

Expert Review of Proteomics

Volumn 2, Issue 4, 2005, Pages 577-588

  Bernhard, Oliver K ^b   Diefenbach, Russell J ^a   Cunningham, Anthony L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Assembly; Crosslinking; Herpes simplex virus; HIV; Protein complexes; Virus entry; Virus receptor; Virus transport

Indexed keywords

ANTIVIRUS AGENT; BAY 571293; BILS 179 BS; CD209 ANTIGEN; CD4 ANTIGEN; CD98 ANTIGEN; CELL PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENFUVIRTIDE; GLYCOPROTEIN GP 120; LECTIN; LECTIN RECEPTOR; MEMBRANE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR;

CELL SURFACE; DENDRITIC CELL; DNA MICROARRAY; HERPES; HERPES SIMPLEX VIRUS; HUMAN; IN VIVO CULTURE; MASS SPECTROMETRY; MOLECULAR MECHANICS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RECEPTOR BINDING; REVIEW; VIROLOGY; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS MORPHOLOGY;

ANIMALS; CELL MEMBRANE; HUMANS; MOLECULAR CONFORMATION; PROTEIN BINDING; PROTEOMICS; RECEPTORS, VIRUS; VIRAL PROTEINS;

SIMPLEXVIRUS;

EID: 23744458104     PISSN: 14789450     EISSN: None     Source Type: Journal    
DOI: 10.1586/14789450.2.4.577     Document Type: Review

References (59)

1. Kellam P. Post-genomic virology: the impact of bioinformatics, microarrays and proteomics on investigating host and pathogen interactions. Rev. Med. Virol. 11(5), 313-329 (2001). Examines the role of the new genomics and proteomics technologies and bioinformatics with specific reference to microbial pathogens and viruses.
2. Korth MJ, Katze MG. Unlocking the mysteries of virus-host interactions: does functional genomics hold the key? Ann. NY Acad. Sci. 975, 160-168 (2002). Examines the role of the new genomics and proteomics technologies and bioinformatics with specific reference to microbial pathogens and viruses.
3. Misumi S, Fuchigami T, Takamune N, Takahashi I, Takama M, Shoji S. Three isoforms of cyclophilin A associated with human immunodeficiency virus Type 1 were found by proteomics by using two-dimensional gel electrophoresis and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Virol. 76(19), 10000-10008 (2002). Combines fractionation approaches prior to identification of proteins/peptides by mass spectometry (MS). Represents one of the most comprehensive analyses of virion protein components and viral-cellular protein interactions to date.
4. Johannsen E, Luftig M, Chase MR et al. Proteins of purified Epstein-Barr virus. Proc. Natl Acad. Sci. USA 101(46), 16286-16291 (2004). Combines fractionation approaches prior to identification of proteins/peptides by mass spectometry (MS). Represents one of the most comprehensive analyses of virion protein components and viral-cellular protein interactions to date.
5. Kattenhorn LM, Mills R, Wagner M et al. Identification of proteins associated with murine cytomegalovirus virions. J. Virol. 78(20), 11187-11197 (2004). Combines fractionation approaches prior to identification of proteins/peptides by mass spectometry (MS). Represents one of the most comprehensive analyses of virion protein components and viral-cellular protein interactions to date.
6. Zhu FX, Chong JM, Wu L, Yuan Y. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79(2), 800-811 (2005). Combines fractionation approaches prior to identification of proteins/peptides by mass spectometry (MS). Represents one of the most comprehensive analyses of virion protein components and viral-cellular protein interactions to date.
7. Taylor TJ, Knipe DM. Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J. Virol. 78(11), 5856-5866 (2004). Combines fractionation approaches prior to identification of proteins/peptides by mass spectometry (MS). Represents one of the most comprehensive analyses of virion protein components and viral-cellular protein interactions to date.
8. Fontaine-Rodriguez EC, Taylor TJ, Olesky M, Knipe DM. Proteomics of herpes simplex virus infected cell protein 27: association with translation initiation factors. Virology 330(2), 487-492 (2004). Combines fractionation approaches prior to identification of proteins/peptides by mass spectometry (MS). Represents one of the most comprehensive analyses of virion protein components and viral-cellular protein interactions to date.
9. You J, Croyle JL, Nishimura A, Ozato K, Howley PM. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117(3), 349-360 (2004).
10. Brasier AR, Spratt H, Wu Z et al. Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresis. J. Virol. 78(21), 11461-11476 (2004).
11. Liu HL, Hsu JP. Recent developments in structural proteomics for protein structure determination. Proteomics 5(8), 2056-2068 (2005).
12. Randall AZ, Baldi P, Villarreal LP. Structural proteomics of the poxvirus family. Artif. Intell. Med. 31(2), 105-115 (2004).
13. McDonald TP, Pitt AR, Brown G, Rixon HW, Sugrue RJ. Evidence that the respiratory syncytial virus polymerase complex associates with lipid rafts in virus-infected cells: a proteomic analysis. Virology 330(1), 147-157 (2004).
14. Persidsky Y, Gendelman HE. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J. Leukoc. Biol. 74(5), 691-701 (2003).
15. Wojna V, Carlson KA, Luo X et al. Proteomic fingerprinting of human immunodeficiency virus Type 1-associated dementia from patient monocyte-derived macrophages: a case study. J. Neurovirol. 10(1), 74-81 (2004).
16. Yokoyama Y, Kuramitsu Y, Takashima M et al. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 4(7), 2111-2116 (2004).
17. Takashima M, Kuramitsu Y, Yokoyama Y et al. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 3(12), 2487-2493 (2003).
18. Arnaud MC, Gazarian T, Rodriguez YP, Gazarian K, Sakanyan V. Array assessment of phage-displayed peptide mimics of human immunodeficiency virus type 1 gp41 immunodominant epitope: binding to antibodies of infected individuals. Proteomics 4(7), 1959-1964 (2004).
19. Greenberg M, Cammack N, Salgo M, Smiley L. HIV fusion and its inhibition in antiretroviral therapy. Rev. Med. Virol. 14(5), 321-327 (2004). Recent review of a new target for anti-HIV drugs, through the inhibition of fusion of the virus with the cell membrane. These inhibitors prevent conformational changes in gp41 and include the drug T20, which is now in clinical practice
20. Maeda K, Nakata H, Ogata H, Koh Y, Miyakawa T, Mitsuya H. The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection. Curr. Opin. Pharmacol. 4(5), 447-452 (2004). Examines another new target for anti-HIV drugs, blockade of the binding of gp120 to the fusion receptor CCR5, after the virus has bound to CD4. Such drugs are now in clinical trials.
21. Kawamura T, Bruse SE, Abraha A et al. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. J. Virol. 78(14), 7602-7609 (2004).
22. Gingras AC, Aebersold R, Raught B. Advances in protein complex analysis using mass spectrometry. J. Physiol. 563(Pt 1), 11-21 (2005).
23. Zhu H, Bilgin M, Snyder M. Proteomics. Ann. Rev. Biochem. 72, 783-812 (2003).
24. Simpson RJ. Proteins and proteomics. A laboratory manual. (2003). Excellent practical guide to proteomics.
25. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 422(6928), 198-207 (2003). Excellent recent review of MS-based proteomics.
26. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75(17), 4646-4658 (2003).
27. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74(20), 5383-5392 (2002).
28. Eddes JS, Kapp EA, Frecklington DF et al. CHOMPER: a bioinformatic tool for rapid validation of tandem mass spectrometry search results associated with high-throughput proteomic strategies. Proteomics 2(9), 1097-1103 (2002).
29. Xiao X, Wu L, Stantchev TS et al. Constitutive cell surface association between CD4 and CCR5. Proc. Natl Acad. Sci. USA 96(13), 7496-7501 (1999).
30. Gavin AC, Bosche M, Krause R et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415(6868), 141-147 (2002). In this large-scale proteomics study, a comprehensive protein interaction map was established using a combination of affinity tag purification and MS.
31. Graziani-Bowering G, Filion LG, Thibault P, Kozlowski M. CD4 is active as a signaling molecule on the human monocytic cell line Thp-1. Exp. Cell Res. 279(1), 141-152 (2002).
32. Bernhard OK, Cunningham AL, Sheil MM. Analysis of proteins copurifying with the CD4/lck complex using one-dimensional polyacrylamide gel electrophoresis and mass spectrometry: comparison with affinity-tag based protein detection and evaluation of different solubilization methods. J. Am. Soc. Mass Spectrom. 15(4), 558-567 (2004). Examines different strategies for identifying membrane proteins interacting with CD4, indicating the problems with false positives and the advantages and disadvantages of a variety of proteomics approaches.
33. Bernhard OK, Burgess JA, Hochgrebe T, Sheil MM, Cunningham AL. Mass spectrometry analysis of CD4-associating proteins using affinity chromatography and affinity tag-mediated purification of tryptic peptides. Proteomics 3(2), 139-146 (2003). Examines different strategies for identifying membrane proteins interacting with CD4, indicating the problems with false positives and the advantages and disadvantages of a variety of proteomics approaches.
34. Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nature Neurosci. 3(7), 661-669 (2000).
35. Blagoev B, Ong SE, Kratchmarova I, Mann M. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nature Biotechnol. 22(9), 1139-1145 (2004).
36. Ranish JA, Yi EC, Leslie DM et al. The study of macromolecular complexes by quantitative proteomics. Nature Genet. 33(3), 349-355 (2003).
37. Dornan S, Sebestyen Z, Gamble J et al. Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p561ck tyrosine kinase in T-cell antigen receptor signal transduction. J. Biol. Chem. 277(3), 1912-1918 (2002).
38. Bernhard OK, Sheil MM, Cunningham AL. Lateral membrane protein associations of CD4 in lymphoid cells detected by cross-linking and mass spectrometry. Biochemistry 43(1), 256-264 (2004).
39. Mitchell DA, Fadden AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276(31), 28939-28945 (2001).
40. Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW. The organizing principle in the formation of the T-cell receptor-D3 complex. Cell 111(7), 967-979 (2002).
41. Bernhard OK, Lai J, Wilkinson J, Sheil MM, Cunningham AL. Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4. J. Biol. Chem. 279(50), 51828-51835 (2004). Demonstrates the use of proteomics techniques and short-range crosslinkers for defining the tertiary structure of DC-SIGN on dendritic cells and its interaction partners (or lack of them). The clarity of the results, even with membrane proteins, is apparent.
42. Kleymann G. Novel agents and strategies to treat herpes simplex virus infections. Expert Opin. Investig. Drugs 12(2), 165-183 (2003).
43. Kleymann G. New antiviral drugs that target herpesvirus helicase primase enzymes. Herpes 10(2), 46-52 (2003).
44. Kleymann G. Helicase primase: targeting the Achilles heel of herpes simplex viruses. Antivir. Chem. Chemother. 15(3), 135-140 (2004).
45. Visalli RJ, van Zeijl M. DNA encapsidation as a target for antiherpesvirus drug therapy. Antiviral Res. 59(2), 73-87 (2003).
46. Diefenbach RJ, Miranda-Saksena M, Diefenbach E et al. Herpes simplex virus tegument protein US 11 interacts with conventional kinesin heavy chain. J. Virol. 76(7), 3282-3291 (2002).
47. Douglas MW, Diefenbach RJ, Homa FL et al. Herpes simplex virus Type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transport. J. Biol. Chem. 279(27), 28522-28530 (2004). Highlights the use of screening with the yeast two-hybrid assay to identify viral-viral and viral-cellular protein interactions.
48. Vittone V, Diefenbach E, Triffett D, Douglas MW, Cunningham AL, Diefenbach RJ. Determination of interactions between tegument proteins of herpes simplex virus Type 1. J. Virol. 79(15), 9566-9571 (2005). Highlights the use of screening with the yeast two-hybrid assay to identify viral-viral and viral-cellular protein interactions.
49. Fields S, Song O. A novel genetic system to detect protein-protein interactions. Nature 340(6230), 245-246 (1989).
50. Gyuris J, Golemis E, Chertkov H, Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75(4), 791-803 (1993).
51. Causier B. Studying the interactome with the yeast two-hybrid system and mass spectrometry. Mass Spectrom. Rev. 23(5), 350-367 (2004).
52. Mettenleiter TC. Budding events in herpesvirus morphogenesis. Virus Res. 106(2), 167-180 (2004).
53. Klupp BG, Fuchs W, Granzow H, Nixdorf R, Mettenleiter TC. Pseudorabies virus UL36 tegument protein physically interacts with the UL37 protein. J. Virol. 76(6), 3065-3071 (2002).
54. Terpe K. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 60(5), 523-533 (2003).
55. Mazzulli T, Low DE, Poutanen SM. Proteomics and severe acute respiratory syndrome (SARS): emerging technology meets emerging pathogen. Clin. Chem. 51(1), 6-7 (2005).
56. Labaer J, Ramachandran N. Protein microarrays as tools for functional proteomics. Curr. Opin. Chem. Biol. 9(1), 14-19 (2005).
57. Sakanyan V. High-throughput and multiplexed protein array technology: protein-DNA and protein-protein interactions. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 815(1-2), 77-95 (2005).
58. Davies DH, Liang X, Hernandez JE et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl Acad. Sci. USA 102(3), 547-552 (2005).
59. Yuk CS, Lee HK, Kim HT et al. Development and evaluation of a protein microarray chip for diagnosis of hepatitis C virus. Biotechnol. Lett. 26(20), 1563-1568 (2004).